Skip to content
PoliTrackerPrototype - alpha version 0.1
← Policies

Proposed

Bill · 119th Congress · S 3325

Expanding Access to Affordable Drugs and Medical Devices Act

Refreshed 6 h ago

Introduced 2025-12-03Topic: health care · taxes · public health

Summary

AI-generated summary, report an error

This bill would let the Treasury Secretary, working with the Secretary of Health and Human Services, designate certain nonprofit groups that make or distribute drugs or medical devices as "public interest drug or medical device health care organizations." Designated groups would keep their tax-exempt charity status even though they make or sell these products. To qualify, a group's main purpose must be making eligible drugs or devices affordable, it must be based and mainly operated in the United States, and it must limit board and staff ties to for-profit drug or device companies. Eligible products must be in shortage or expected to lower costs, plus meet another need such as an unmet health need or emergency supply. Groups must agree to give the federal government priority to buy at least 25 percent of their output for the national stockpile when needed, and the bill treats certain outside funders as subject to excess benefit tax rules.

Full text and official record on Congress.gov

Sponsors

Action history

DateChamberActionStatus effect
2025-12-03SenateRead twice and referred to the Committee on Finance.refer
2025-12-03Introduced in Senateintroduce
Source: GovInfo Bill Status (Library of Congress), fetched 2026-09-11. Provisions and opinion polling arrive in a later release.